Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX) Meeting Abstract
| Authors: | Hecht, J. R.; Naing, A.; Falchook, G. S.; Patel, M. R.; Aljumaily, R.; Wong, D. J.; Autio, K. A.; Wainberg, Z. A.; Javle, M.; Bendell, J.; Pant, S.; Hung, A.; Oft, M.; Leveque, J.; Papadopoulos, K. P. |
| Abstract Title: | Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy288.016 |
| Language: | English |
| ACCESSION: | WOS:000459277302322 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy288.016 |
| Notes: | Meeting Abstract: 1143P -- Appears on page viii406 of the abstract book -- Source: Wos |
